Endocyte Inc (ECYT.OQ)
9.33USD
26 Apr 2018
$0.30 (+3.32%)
$9.03
$9.03
$9.47
$8.95
162,945
453,922
$11.54
$1.17
Latest Key Developments (Source: Significant Developments)
Partner Fund Management LP reports a 6.6 pct passive stake in Endocyte as of Nov 6
Nov 16 (Reuters) - Endocyte Inc
Endocyte Q3 loss per share $0.55
Nov 6 (Reuters) - Endocyte Inc
Endocyte Inc files for mixed shelf of upto $150 million
Oct 12 (Reuters) - Endocyte Inc
Peter Dodwell reports 7.1 pct passive stake in Endocyte Inc
Oct 12 (Reuters) - Endocyte Inc
Endocyte reports Q2 loss per share $0.33
Endocyte Inc
BRIEF-Endocyte Says Data Presented At AACR Show That EC17 Penetrates Solid Tumors Within Minutes And Is Retained Due To High Affinity For Folate Receptor
* ENDOCYTE INC - DATA PRESENTED AT AACR SHOW THAT EC17 PENETRATES SOLID TUMORS WITHIN MINUTES AND IS RETAINED DUE TO HIGH AFFINITY FOR FOLATE RECEPTOR Source text for Eikon: Further company coverage: